In this study, we revealed that the expression level of USP52 and ASF1A is upregulated in breast cancer and positively correlates with each other, and, indeed, USP52-promoted ASF1A stabilization is required for breast cancer cells to combat with genotoxic insults. This evidence concerns the gene ASF1A and breast carcinoma.